Finding the Dose for Hydroxychloroquine Prophylaxis for COVID‐19: The Desperate Search for Effectiveness-Reference-Cited by-同舟云学术

Finding the Dose for Hydroxychloroquine Prophylaxis for COVID‐19: The Desperate Search for Effectiveness

Published:2020-06 Issue:4 Volume:108 Page:766-769
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Al‐Kofahi Mahmoud¹,Jacobson Pamala¹,Boulware David R.²,Matas Arthur³,Kandaswamy Raja³,Jaber Mutaz M.¹,Rajasingham Radha²,Young Jo‐Anne H.²,Nicol Melanie R.¹

Affiliation:

1. Department of Experimental and Clinical Pharmacology College of Pharmacy University of Minnesota Minneapolis Minnesota USA

2. Department of Medicine Medical School University of Minnesota Minneapolis Minnesota USA

3. Department of Surgery Medical School University of Minnesota Minneapolis Minnesota USA

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1874

Reference14 articles.

1. Discovering drugs to treat coronavirus disease 2019 (COVID-19)

2. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

3. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2);Yao X.;Clin. Infect. Dis.

4. Towards optimization of hydroxychloroquine dosing in intensive care unit COVID‐19 patients;Perinel S.;Clin. Infect. Dis.

5. Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Exposure Prophylaxis for COVID-19: A Systematic Review;Infectious Disorders - Drug Targets;2023-08

2. Antimalarials and macrolides: a review of off-label pharmacotherapies during the first wave of the SARS-CoV-2 pandemic;Brazilian Journal of Pharmaceutical Sciences;2023

3. Fluoxetine pharmacokinetics and tissue distribution quantitatively supports a therapeutic role in COVID-19 at a minimum dose of 20 mg per day;F1000Research;2022-10-13

4. Systemic exposure to hydroxychloroquine and its relationship with outcome in severely ill COVID‐19 patients in New York City;British Journal of Clinical Pharmacology;2022-08-29

5. Population Pharmacokinetics of Hydroxychloroquine Sulfate in Healthcare Workers, Given for Prophylaxis Against Coronavirus Disease 2019 (COVID‐19) in India;The Journal of Clinical Pharmacology;2022-06-30